More Adventurous With Automation with Veronica Breene cover art

More Adventurous With Automation with Veronica Breene

More Adventurous With Automation with Veronica Breene

Listen for free

View show details

About this listen

Episode 6: More Adventurous With Automation with Veronica Breene

Host Siobhán Smith welcomes Veronica Breene, Head of Data Science & Insights, Ethics Risk & Compliance at Novartis. Novartis is a leading global medicines company, with over 110,000 employees worldwide that provides solutions to address the evolving needs of patients. They claim to use innovative science and digital technologies to create transformative treatments in areas of great medical need. This as you can imagine, is intrinsically linked to Veronica’s role.  

Veronica has over 15 years’ experience working in the data field and has held several senior strategic roles in Data Science, Data Management and Data Strategy across a wide variety of industries. She has an MBA and is a PHD Candidate in Explainable AI. 

Join the conversation online using the hashtag #ExpleoExplores 

Download the Business Transformation Index (BTI) 2022 report: expleo.com/bti-2022/ 

Send us your feedback: info@expleogroup.com 

About the Business Transformation Index (BTI) 2022 

Expleo’s annual Business Transformation Index report surveys over 1000 senior decision makers in global organisations of 5000+* about their transformation initiatives. The report provides a holistic overview of the 9 critical success factors underpinning successful transformation. The report is free and available here: expleo.com/bti-2022/ 

About Expleo 

Expleo is a global engineering, technology and consulting service provider that partners with leading organisations to guide them through their business transformation, helping them achieve operational excellence and future-proof their businesses. We have a wide range of expertise and over 30 years’ experience in successful transformation. Talk to us today! Expleo.com 

*this benchmark was lowered to 1000 in Ireland due to the size of the market 

No reviews yet